These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8727096

  • 1. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
    Oda Y, Schneider-Stock R, Ryś J, Gruchała A, Niezabitowski A, Roessner A.
    Diagn Mol Pathol; 1996 Jun; 5(2):98-106. PubMed ID: 8727096
    [Abstract] [Full Text] [Related]

  • 2. Expression of multidrug-resistance-associated protein gene in human soft-tissue sarcomas.
    Oda Y, Schneider-Stock R, Ryś J, Gruchala A, Niezabitowski A, Roessner A.
    J Cancer Res Clin Oncol; 1996 Jun; 122(3):161-65. PubMed ID: 8601564
    [Abstract] [Full Text] [Related]

  • 3. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.
    Oda Y, Röse I, Radig K, Wagemann W, Mittler U, Roessner A.
    Virchows Arch; 1997 Feb; 430(2):99-105. PubMed ID: 9083512
    [Abstract] [Full Text] [Related]

  • 4. Expression of MDR1/P glycoprotein in human sarcomas.
    Vergier B, Cany L, Bonnet F, Robert J, de Mascarel A, Coindre JM.
    Br J Cancer; 1993 Dec; 68(6):1221-6. PubMed ID: 7903154
    [Abstract] [Full Text] [Related]

  • 5. Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patients.
    Stein U, Wunderlich V, Haensch W, Schmidt-Peter P.
    Eur J Cancer; 1993 Dec; 29A(14):1979-81. PubMed ID: 7904171
    [Abstract] [Full Text] [Related]

  • 6. ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas.
    Oda Y, Saito T, Tateishi N, Ohishi Y, Tamiya S, Yamamoto H, Yokoyama R, Uchiumi T, Iwamoto Y, Kuwano M, Tsuneyoshi M.
    Int J Cancer; 2005 May 10; 114(6):854-62. PubMed ID: 15609299
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
    Yoshikawa H, Rettig WJ, Lane JM, Takaoka K, Alderman E, Rup B, Rosen V, Healey JH, Huvos AG, Garin-Chesa P.
    Cancer; 1994 Aug 01; 74(3):842-7. PubMed ID: 8039112
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):403-16. PubMed ID: 10606188
    [Abstract] [Full Text] [Related]

  • 10. Determining MDR1/P-glycoprotein expression in breast cancer.
    Faneyte IF, Kristel PM, van de Vijver MJ.
    Int J Cancer; 2001 Jul 01; 93(1):114-22. PubMed ID: 11391630
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities.
    Serra M, Scotlandi K, Manara MC, Maurici D, Benini S, Sarti M, Nini G, Barbanti-Brodano G, Baldini N.
    Cytotechnology; 1996 Jul 01; 19(3):253-6. PubMed ID: 8862015
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C, Renner M, Hartmann W, Brandt R, Lehner B, Waldburger N, Alldinger I, Schmitt T, Egerer G, Penzel R, Wardelmann E, Schirmacher P, von Deimling A, Mechtersheimer G.
    J Exp Clin Cancer Res; 2014 Apr 11; 33(1):33. PubMed ID: 24726063
    [Abstract] [Full Text] [Related]

  • 14. Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.
    Stein U, Walther W, Wunderlich V.
    Eur J Cancer; 1994 Apr 11; 30A(10):1541-5. PubMed ID: 7833115
    [Abstract] [Full Text] [Related]

  • 15. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
    Taubert H, Würl P, Meye A, Berger D, Thamm B, Neumann K, Hinze R, Schmidt H, Rath FW.
    Cancer; 1995 Oct 01; 76(7):1187-96. PubMed ID: 8630896
    [Abstract] [Full Text] [Related]

  • 16. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.
    Hegewisch-Becker S, Staib F, Löning T, Pichlmeier U, Kröger N, Reymann A, Hossfeld DK.
    Ann Oncol; 1998 Jan 01; 9(1):85-93. PubMed ID: 9541688
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas.
    Ueda T, Oji Y, Naka N, Nakano Y, Takahashi E, Koga S, Asada M, Ikeba A, Nakatsuka S, Abeno S, Hosen N, Tomita Y, Aozasa K, Tamai N, Myoui A, Yoshikawa H, Sugiyama H.
    Cancer Sci; 2003 Mar 01; 94(3):271-6. PubMed ID: 12824921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O.
    J Natl Cancer Inst; 1994 Sep 07; 86(17):1297-302. PubMed ID: 8064888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.